Publication date: Jun 28, 2025
Pediatric COVID-19 vaccination reduces symptomatic infections and hospitalizations. However, race-based disparities in pediatric COVID-19 vaccine uptake in Canada remain underexplored, despite well-documented inequities among adults. This study examines racial disparities in pediatric COVID-19 vaccine coverage in Canada and identifies key predictors, including structural and individual-level factors. A cross-sectional survey was conducted among a nationally representative and ethnically diverse sample of 2528 parents of 4386 children aged 0-12 years in Canada. Parents completed measures assessing child’s COVID-19 vaccine uptake, COVID-19 vaccine mistrust, health literacy, experiences of racial discrimination, and child’s prior COVID-19 infection. Adjusted odd ratios was performed to identify factors associated with vaccine uptake. Overall pediatric vaccine coverage was 56. 8 %. Coverage was lowest among children of Black (39. 4 %, 95 % CI: 35. 4, 43. 5) and Arab (42. 9 %, 95 % CI: 38. 4, 47. 5) parents, compared to White (59. 5 %, 95 % CI: 57. 4, 61. 5) and Asian (71. 6 %, 95 % CI: 67. 3, 75. 6) parents (p
Open Access PDF
| Concepts | Keywords |
|---|---|
| 12years | Canada |
| Canada | Child |
| Hospitalizations | COVID-19 vaccine uptake |
| Literacy | Racial disparities |
| Racial |
Semantics
| Type | Source | Name |
|---|---|---|
| disease | MESH | COVID-19 |
| disease | MESH | infections |
| disease | IDO | infection |
| drug | DRUGBANK | Abacavir |
| disease | MESH | morbidity |
| disease | MESH | infectious diseases |
| disease | MESH | measles |
| pathway | KEGG | Measles |
| drug | DRUGBANK | Coenzyme M |
| disease | MESH | education level |
| disease | IDO | history |
| disease | IDO | process |
| disease | MESH | marital status |
| disease | MESH | preterm birth |
| disease | MESH | unemployment |
| disease | IDO | role |